Fractyl Health’s GLP-1 gene therapy spurs 25% weight loss in obese mice, clinical trials slated for 2024news2023-10-04T09:30:27+00:00October 4th, 2023|Endpoints News|
Updated: Sanofi’s $1.5B deal with Teva in IBD adds fuel to anti-TL1A race against Merck, Roivant and Pfizernews2023-10-04T07:49:35+00:00October 4th, 2023|Endpoints News|
Vertex says another type 1 diabetes patient is insulin-free after islet cell therapy in detailed data at EASDnews2023-10-03T22:01:53+00:00October 3rd, 2023|Endpoints News|
Clinical efficacy studies should not be the default for biosimilars development, FDA saysnews2023-10-03T19:35:51+00:00October 3rd, 2023|Endpoints News|
Wegovy, Ozempic exclusivity challenges denied by US patent appeal boardnews2023-10-03T19:27:43+00:00October 3rd, 2023|Endpoints News|
FDA clears Novavax’s fall booster for Covid-19, weeks after mRNA vaccine boosters news2023-10-03T18:53:36+00:00October 3rd, 2023|Endpoints News|
FDA offers positive signals for potential pediatric neuroblastoma drug ahead of ODAC meetingnews2023-10-03T17:48:17+00:00October 3rd, 2023|Endpoints News|
MarketingRx roundup: Pharmas nab ‘greenest’ awards; Gilead sponsors ESG executive conferencenews2023-10-03T16:53:18+00:00October 3rd, 2023|Endpoints News|
Health tech funding levels out as startups raise $2.5B in third quarternews2023-10-02T19:16:09+00:00October 2nd, 2023|Endpoints News|
Horizon debuts latest thyroid eye disease TV commercials as Amgen merger nearsnews2023-10-02T19:00:39+00:00October 2nd, 2023|Endpoints News|
